According to a new report, published by KBV research, The Global AI In Medical Writing Market size is expected to reach $1.72 billion by 2031, rising at a market growth of 12.2% CAGR during the forecast period.
The Type Writing segment is leading the Global AI In Medical Writing Market by Type in 2023; thereby, achieving a market value of $484.9 Million by 2031. This segment benefits from the high demand for streamlined processes to generate standard regulatory documents and medical protocols. AI technologies excel in automating repetitive writing tasks, ensuring consistency and adherence to strict regulatory frameworks. This segment is also driven by the need for cost-effective solutions in the pharmaceutical industry, where AI reduces time and resource requirements, making it a preferred choice for documentation.
The Biotechnology segment is anticipating a CAGR of 12.4% during (2024 - 2031). The segment is propelled by the sector's focus on innovation and advanced research, which requires precise, high-quality documentation. AI technologies support the creation of grant proposals, research summaries, and scientific publications by analyzing complex datasets and generating well-structured content. As biotechnology firms explore cutting-edge fields like genomics, proteomics, and personalized medicine, AI-powered medical writing tools have become indispensable for presenting complex scientific information accurately and efficiently.
Full Report: https://www.kbvresearch.com/ai-in-medical-writing-market/
The North America region dominated the Global AI In Medical Writing Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $571.8 Million by 2031. The Europe region is experiencing a CAGR of 11.8% during (2024 - 2031). Additionally, The Asia Pacific region would showcase a CAGR of 12.8% during (2024 - 2031).
By Type
By End Use